Press Releases
-
Jul 8, 2019First Natesto Study to Demonstrate Efficacy in Severely Hypogonadal Patients...Jul 1, 2019ENGLEWOOD, CO / ACCESSWIRE / July 1, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced that it has been added to the Russell Microcap® Index effective after the U.S. markets open today, July 1, 2019....Jun 25, 2019First Clinical Data Demonstrating Predictive Power of Seminal Oxidation-Reduction Potential (ORP) as a Predictor of Fertilization When Used Prior to IVF ...Jun 24, 2019ENGLEWOOD, CO / ACCESSWIRE / June 24, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced that the MiOXSYS® male infertility test will be featured today in a Product Theatre symposium at the 35th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE)...Jun 18, 201911 Abstracts Featuring MiOXSYS have been Selected for Presentation at the 35th Annual Meeting of the European Society of Human Reproduction and Embryology...Jun 12, 2019ENGLEWOOD, CO / ACCESSWIRE / June 12, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, today announced that Natesto® has been featured on KPRC-TV, an NBC-affiliated television station in Houston, Texas, in a segment titled: 'Nasal spray for low testosterone preserves fertility.'...Jun 11, 2019ENGLEWOOD, CO / ACCESSWIRE / June 11, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, is set to join the Russell Microcap® Index at the conclusion of the 2019 Russell indexes annual reconstitution. This will be effective after the US market opens on July 1, according to a preliminary ...Jun 4, 2019Initial Purchase by Beijing Dahua Sanxin Technology Development Co., Ltd. Represents First MiOXSYS Commercial Sale in China....May 21, 2019Aytu BioScience Announces Availability of the MiOXSYS(R) Male Infertility Test in the United KingdomENGLEWOOD, CO / ACCESSWIRE / May 21, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, today announced that MiOXSYS®, the company's first-in-class seminal oxidative stress test for the assessment of male infertility, is now available in the United Kingdom....May 14, 2019Company Posts Highest Ever Quarterly Revenue...